NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system ...

NLS Pharmaceutics AG (NLSP) stock has hit a 52-week low, trading at $1.73, with a market capitalization of just $2.94 million ...

RSC Pharmaceutics acknowledges how chemistry and related disciplines can make a big difference. This impactful journal provides you with a platform to publish crucial research on pharmaceutics. This ...

The doctoral program in Pharmaceutical Sciences at LIU is designed to prepare students to meet the challenges and the current needs of scientists engaged in the pharmaceutical sciences and drug ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks NLS Pharmaceutics ( (NLSP)) has shared an update. NLS Pharmaceutics and Kadimastem, in collaboration with ...

Interested in a career in drug development or research? This one-year Pharmaceutics MSc will equip you with sought-after expertise in all the different stages of medicine design, so you can learn how ...

NLS Pharmaceutics (NLSP) and Kadimastem announced that Kadimastem has issued a notice to convene a special general meeting of Kadimastem’s ...

Centers for Disease Control and Prevention (the "CDC") reported 105,007 drug overdose deaths - with 90% involving synthetic opioids like fentanyl Mazindol ER potentially ...

NLS Pharmaceutics (NLSP) and Kadimastem, a clinical-stage cell therapy company specializing in the treatment of neurodegenerative diseases and ...